Advice
Recommended for restricted use within NHS Scotland.
RECOMMENDATION.
Telmisartan / hydrochlorothiazide (MicardisPlus®) has efficacy similar to the antihypertensive effects of the individual constituents added together in the treatment of essential hypertension. No increased costs are associated with this product compared with telmisartan (Micardis®) alone. Angiotensin II receptor antagonists are an alternative to ACE inhibitors where these are not tolerated.
Download detailed advice41KB (PDF)
Medicine details
- Medicine name:
- Telmisartan/hydrochlorothiazide (MicardisPlus®)
- SMC ID:
- 39/03
- Indication:
- Essential hypertension
- Pharmaceutical company
- Boehringer Ingelheim Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Full
- Status
- Restricted
- Date advice published
- 09 May 2003